Cargando…

Predictive Value of Reactogenicity for Anti-SARS-CoV-2 Antibody Response in mRNA-1273 Recipients: A Multicenter Prospective Cohort Study

Messenger RNA (mRNA) vaccination was developed to mitigate the coronavirus disease 2019 pandemic. However, data on antibody kinetics and factors influencing these vaccines’ immunogenicity are limited. We conducted a prospective study on healthy young adults who received two doses of the mRNA-1273 va...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Min Joo, Heo, Jung Yeon, Seo, Yu Bin, Yoon, Young Kyung, Sohn, Jang Wook, Noh, Ji Yun, Cheong, Hee Jin, Kim, Woo Joo, Choi, Ju-yeon, Lee, Young Jae, Lee, Hye Won, Kim, Sung Soon, Kim, Byoungguk, Song, Joon Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862064/ https://www.ncbi.nlm.nih.gov/pubmed/36679965 http://dx.doi.org/10.3390/vaccines11010120

Ejemplares similares

Six-month longitudinal immune kinetics after mRNA-1273 vaccination: Correlation of peak antibody response with long-term, cross-reactive immunity
por: Choi, Min Joo, et al.
Publicado: (2023)

Immunogenicity and Reactogenicity of Ad26.COV2.S in Korean Adults: A Prospective Cohort Study
por: Hyun, Hakjun, et al.
Publicado: (2022)

Robust neutralizing antibody responses after single-dose BNT162b2 vaccination at long intervals from prior SARS-CoV-2 infection and ceiling effect with repeated vaccination
por: Noh, Ji Yun, et al.
Publicado: (2022)

COVID-19 vaccine type-dependent differences in immunogenicity and inflammatory response: BNT162b2 and ChAdOx1 nCoV-19
por: Heo, Jung Yeon, et al.
Publicado: (2022)

Reactogenicity to the mRNA-1273 Booster According to Previous mRNA COVID-19 Vaccination
por: Parés-Badell, Oleguer, et al.
Publicado: (2022)

Cross-neutralization of Omicron subvariants after heterologous NVX-CoV2373 boosters: Comparison between prior SARS-CoV-2-infected and infection-naive individuals
por: Choi, Min Joo, et al.
Publicado: (2023)

Immunogenicity and reactogenicity of heterologous and homologous mRNA-1273 and BNT162b2 vaccination: A multicenter non-inferiority randomized trial
por: Janssen, Cécile, et al.
Publicado: (2022)

Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers
por: Tré-Hardy, Marie, et al.
Publicado: (2021)

Heterologous ChAdOx1 and Bnt162b2 vaccination induces strong neutralizing antibody responses against SARS-CoV-2 including delta variant with tolerable reactogenicity
por: Bae, Seongman, et al.
Publicado: (2022)

Clinical and economic burden of invasive pneumococcal disease in adults: a multicenter hospital-based study
por: Song, Joon Young, et al.
Publicado: (2013)

Clinical Characteristics and Outcomes of Acute Hepatitis A in Korea: A Nationwide Multicenter Study
por: Kwon, So Young, et al.
Publicado: (2014)

Incidence and case fatality rates of community-acquired pneumonia and pneumococcal diseases among Korean adults: Catchment population-based analysis
por: Heo, Jung Yeon, et al.
Publicado: (2018)

Herpes Zoster Reactivation After mRNA and Adenovirus-Vectored Coronavirus Disease 2019 Vaccination: Analysis of National Health Insurance Database
por: Yoon, Jin Gu, et al.
Publicado: (2023)

Knife’s edge: Balancing immunogenicity and reactogenicity in mRNA vaccines
por: Lee, Jisun, et al.
Publicado: (2023)

Outpatient-Based Pneumococcal Vaccine Campaign and Survey of Perceptions about Pneumococcal Vaccination in Patients and Doctors
por: Song, Joon Young, et al.
Publicado: (2013)

Humoral Immune Response of Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Prime-Boost Vaccination against SARS-CoV-2 Variants in Korea
por: Lim, Heeji, et al.
Publicado: (2023)

Molecular Epidemiology of Human Adenovirus–Associated Febrile Respiratory Illness in Soldiers, South Korea(1)
por: Heo, Jung Yeon, et al.
Publicado: (2018)

Cost-effectiveness of pneumococcal vaccination strategies for the elderly in Korea
por: Heo, Jung Yeon, et al.
Publicado: (2017)

Asymptomatic infection and atypical manifestations of COVID-19: Comparison of viral shedding duration
por: Noh, Ji Yun, et al.
Publicado: (2020)

Liver Abscess and Empyema due to Lactococcus lactis cremoris
por: Kim, Hye Sook, et al.
Publicado: (2010)

Disease burden of hospitalized community-acquired pneumonia in South Korea: Analysis based on age and underlying medical conditions
por: Choi, Min Joo, et al.
Publicado: (2017)

Invasive fungal infection in liver transplant recipients in a prophylactic era: A multicenter retrospective cohort study in Korea
por: Kim, Youn Jeong, et al.
Publicado: (2019)

Antibody Response Induced by Two Doses of ChAdOx1 nCoV-19, mRNA-1273, or BNT162b2 in Liver Transplant Recipients
por: Lim, So Yun, et al.
Publicado: (2022)

Analysis of Myocarditis Among 252 Million mRNA-1273 Recipients Worldwide
por: Straus, Walter, et al.
Publicado: (2022)

Clinical performance of the Sofia™ Influenza A + B FIA in adult patients with influenza-like illness
por: Noh, Ji Yun, et al.
Publicado: (2015)

Reactogenicity and Immunogenicity of the ChAdOx1 nCOV-19 Coronavirus Disease 2019 Vaccine in South Korean Healthcare Workers
por: Hyun, JongHoon, et al.
Publicado: (2022)

Predictors of the Severity and Serious Outcomes of Anaphylaxis in Korean Adults: A Multicenter Retrospective Case Study
por: Ye, Young-Min, et al.
Publicado: (2015)

The Clinical Usefulness of the SD Bioline Influenza Antigen Test® for Detecting the 2009 Influenza A (H1N1) Virus
por: Choi, Won Suk, et al.
Publicado: (2011)

Correlation between Reactogenicity and Immunogenicity after the ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccination
por: Lim, So Yun, et al.
Publicado: (2021)

25. Immunogenicity and Reactogenicity of COVID-19 mRNA Vaccines in Allogeneic Stem Cell Transplant Recipients
por: Bausk, Bruce P, et al.
Publicado: (2021)

Risk factors for SARS-CoV-2 transmission in non-household clusters
por: Noh, Ji Yun, et al.
Publicado: (2021)

Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients
por: Hall, Victoria G., et al.
Publicado: (2021)

Can reactogenicity predict immunogenicity after COVID-19 vaccination?
por: Hwang, Young Hoon, et al.
Publicado: (2021)

Results of Multicenter Phase II Study With Imatinib Mesylate in Allogeneic Recipients With Steroid-Refractory Chronic GVHD
por: Baek, Dong Won, et al.
Publicado: (2022)

A comparison of epidemiology and clinical outcomes between influenza A H1N1pdm09 and H3N2 based on multicenter surveillance from 2014 to 2018 in South Korea
por: Yoon, Jin Gu, et al.
Publicado: (2020)

An outbreak of post-acupuncture cutaneous infection due to Mycobacterium abscessus
por: Song, Joon Young, et al.
Publicado: (2006)

Neutralizing Activity against BQ.1.1, BN.1, and XBB.1 in Bivalent COVID-19 Vaccine Recipients: Comparison by the Types of Prior Infection and Vaccine Formulations
por: Hyun, Hak-Jun, et al.
Publicado: (2023)

The Efficacy and Safety of Ezetimibe and Low-Dose Simvastatin as a Primary Treatment for Dyslipidemia in Renal Transplant Recipients
por: Yoon, Hye Eun, et al.
Publicado: (2009)

In-house Manual Construction of High-Density and High-Quality Tissue Microarrays by Using Homemade Recipient Agarose-Paraffin Blocks
por: Kim, Kyu Ho, et al.
Publicado: (2013)

Pulmonary Embolism and Inferior Vena Cava Thrombosis in a Young Male Patient after mRNA-1273 (Moderna) Immunization: A Case Report
por: Ahn, Eui Young, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vlopedurf4refb1bhhg4e1ifhu